Atlas Trials

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

Clinical trial NCT03477903 · TERMINATED

Trial details

NCT number
NCT03477903
Sponsor
Millennium Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Critical IllnessEnteral NutritionEnteral Feeding Intolerance
Start date
2018-08-25
Primary completion
2018-08-29
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.